This website is dedicated to the millions of thyroid patients who are being ignored and left to suffer unnecessarily, and to healthcare practitioners, who want to better serve those patients.

Open Letter to Dr Mark Vanderpump from Anina (Denmark)

I have permission from Anina to post the following message on to our Forum and also, to add it to our ‘Treasure Chest’ – this is an excellent point to put to your doctor who insists on telling you that there is no difference between synthetic thyroxine and the thyroxine found in natural desiccated porcine thyroid extract – so keep it in a safe place.

Open Letter to Mark Vanderpump United Kingdom

(EditedJune 2, 2015)

Levothyroxine: from sheep thyroid injections to synthetic formulations

The Pharmaceutical Journal, 18 JUL 2013 Jenny Bryan takes a look at the colourful and interesting history of levothryoxine sodium, and the ongoing debate over combination treatment versus monotherapy.

By Jenny Bryan Although synthetic forms of levothyroxine have been available since the 1950s,1 there is continued public demand for porcine thyroxine as a more natural product than the synthetic version. Synthetic levothyroxine is exactly the same as human thyroxine and has the obvious advantage that you dont need to go to an abattoir to get it. But no randomised controlled trials were done to compare the effectiveness of the two products before patients were switched to synthetic treatment, and some patients feel that their symptoms are better controlled with pig thyroid hormone preparations, says Dr Vanderpump.

Read more:…123454.article

Author of this Article, Jenny Bryan has interviewed doctor Mark Vanderpump and his claims I have commented on in the following e-mail to which by the way (of course?) I have not received a reply.

Subject: “Article: “Levothyroxine: from sheep thyroid injections to synthetic formulations”
Date: Fri, 22 May 2015 15:51:43 +0200
From: Me

Dear Dr. Mark Vanderpump

I read with great interest the article “Levothyroxine: from sheep thyroid injections to synthetic formulations” by Jenny Bryan.…123454.article

Based on this article, I would like to make you aware that there is no longer such a thing as “exactly the same as human thyroxine” in relation to synthetic T4 products. Since nature-identical hormone molecules are not patentable, the industry has developed a long range of so-called “thyroxine analogues” consisting many kinds of structure changed molecules which are no longer built exactly as human thyroxine.

I have studied this issue for several years, and after having examined several levothyroxine patents and found the first 29 molecular “versions” of “artificial levothyroxine”, it was no longer necessary to continue because my point was already confirmed 29 times: there is no such a thing as “Synthetic levothyroxine is exactly the same as human thyroxine”.

Regardless that in those artificial T4-molecules the number of atoms of the basic elements remains the same as in human T4-molecule, those atoms are arranged differently, or rotated different from the “real” human thyroxine. Only the first commercial forms of synthetic thyroxine was “nature identical”, which has been the reason for the reasonable good effect, far better than from the following patented T4 analogues.

When a specific molecular structure of a hormone is required before the body can successfully utilize it, it cannot be surprising that treatment with the “changed” thyroxine is insufficient and causes side effects. But even if all those marketed synthetic thyroxine-products consisted of exact molecular copies of the human thyroid hormone, there exists the critical biochemical difference between those synthetics T4-analogues and preparations of animal thyroid gland.

There is no such a thing as a “free thyroxine” in human or animal thyroid gland, while the synthetic thyroxine analogues are only in the free form. Therefore, one cannot compare these two biochemical forms of drugs because their pharmacokinetics and pharmacodynamics are quite different from each other.

In a normal healthy human body the blood contains only 1% free thyroxine of the body’s total (at the time) content of thyroxine. 99% of thyroxine is in a protein-bound state. This means that in the normal human body the thyroxine frees from protein binding only just so much/little that the body’s levels of free thyroxine are constantly maintained at 1%. Therefore, in relation to pharmacokinetic and pharmacodynamic, the drugs made from animal thyroid gland – in the body’s metabolism of thyroid hormones works exactly the same way as if these hormones were released from the thyroid gland itself. That is why the values of free T4 has to be low, and the values of free T3 has to be in the upper third of the reference range in patients who are optimal dosed in the treatment with preparations of animal thyroid gland.

This explains why so many patients prosper so much better with this treatment. In relation to pharmacokinetic and pharmacodynamic of synthetic thyroxine analogues in the human body, works these drugs so the body becomes flooded with free thyroxine to a degree, that in a normal human body this would be called “hyperthyroxinemia”, whereas for some inexplicable reasons – in a hypothyroid bodies, this condition is considered – by the doctors – as “normal”. It’s NOT normal! Too much free thyroxine in the blood at any time, is not normal and the body’s genetic control will always try continuously to break down the excess of free thyroxine.

This explains why so many patients treated with synthetic thyroxine analogues, nevertheless remains sick. I wrote once in the past as a comment to another relevant article:

Now we just hope that at some point we can succeed in explaining to our doctors that the missing link in understanding that the protein binding is the difference between DTE (Desiccated Thyroid Extract) and synthetic T4 analogues. Because 99% of thyroid hormones in the DTE is protein-bound, it means that the pharmacodynamics of DTE happens with Slow Release Effect, eliminating all the talk about the Ratio of T4/T3 and TSH, and making it pointless. All reflections on the ratio of T4 / T3 in thyroid glands of pigs could only make sense in the context of issues associated with transplant surgery between two different species, but in orally ingested drugs it does not matter. Our doctors need to learn about the pharmacokinetics and pharmacodynamics of these two types of drugs, because right now they are committing so many serious mistakes, that their patients basically remains sick.

It is almost impossible, to touch briefly, every detail, including corresponding metabolic aspects of artificial triiodothyronine (synthetic T3) versus protein-bound triiodothyronine (T3) in preparations of animal thyroid gland, which in principle is the same as the difference between metabolic aspects of “real” and “artificial” thyroxine, as well as briefly respond to claims that most patients are comfortable with synthetic therapy, but I try anyway…

The problem is that most hypothyroid patients are women, and a large number of symptoms associated with inadequate treatment of hormone deficiency, are overlapping the most characteristic early and following later signs and symptoms of menopause. This means that as long as doctors choose to interpret the results of inadequate treatment of hypothyroidism, as simple a state of menopause (or simple signs of age in men) – will no positive development happen. Doctors will remain dogmatic instead of knowing, while patients will remain sick.

Please, be aware that while the preparations of animal thyroid gland over the last 120 years has proved their effectiveness and efficiency in the treatment of hypothyroidism, no matter how many new patents are filed in still new artificial synthetic thyroxine “designs” over the last 65 years, they have still not proven their value for the hypothyroid patients. Only for the doctors.

Basically the controversy continues only because those old, animal derived drugs work very satisfactorily, while those new artificial synthetic hormone analogues work only temporarily and incompletely, because of their deviant molecular structures. I remember someone once said: “Hypothyroid patients will continue to suffer as a result of the synthetic treatment, as long as doctors “love” the synthetic treatment more than they “love” their patients.”

Please, always be aware of the difference between knowledge and dogma, because they are so dangerous easy not to notice the difference between.Best regards (me) Denmark

My supplementarycomment, addressed to those who are reading on my own website:

I really begin to suspect that doctors are not as clever as they think they are. There are almost as many interpretations of medical sciences, as there are fractions of doctors on each of the continents. And each of these fractions, mutually monitor each other, terrorizing each other to obedience and punishes those who think more about patients’ best than they wish obey their colleagues (just remember Dr. Skinner and his fate) … I am so close to hate every white coat I see around me, and you know what? They deserve every crumb of this hatred. Millions of people suffers because doctors refuse a drug that works, and favors another drug that does not. This attitude and this decision is pure commercial, and so far from medical sciences as possible. Shame on them.


You must be logged in to post a comment.

Previous comments